Discover why IBB's focused approach makes it preferable to XBI. Learn about their objectives, diversification, and ...

In spite of this underperformance, the clinical-stage TechBio firm continues to attract interest for its innovative approach ...

We start with the ongoing investigation into last month’s fatal Air India crash, after preliminary findings sparked furious ...

Azenta, Inc. made 41 cents a share (non-GAAP) on just over $656 million in revenue in FY2024. The current analyst firm ...

"The future has to be getting people to partner well and create together with the machines," Koller told Fortune.

Plants produce a wide diversity of compounds. Broadly, these are separated into primary metabolites, which are necessary for ...

No administration has been immune to the impulse to investigate leaks. The reflex is bipartisan and familiar: An embarrassing disclosure appears in the press – contradicting official statements or ...

Understand the cash flow statement for Nautilus Biotechnology, Inc. (NAUT), learn where the money comes from and how the company spends it.

This important study looks into the effect of exogenous CoA on the response of TLR4-activated macrophages. Specifically, CoA enhances the LPS response by examining metabolomics, 13C tracing, and ...

For decades, above-the-knee amputees have had to live with stiff, uncomfortable prosthetics that felt more like rigid tools than natural limbs. As a result, climbing stairs, stepping over objects, or ...

IO Biotech Inc. Annual cash flow by MarketWatch. View IOBT net cash flow, operating cash flow, operating expenses and cash dividends.